Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2018-03-07

FDA Approved: ONDANSETRON — Supplemental Application (AvPAK)

View source ↗

Summary

FDA listing shows a supplemental application for ondansetron by AvPAK, likely related to changes to labeling or approved indications for this generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ondansetron (ondansetron)

Snippet

SUPPL AP for ONDANSETRON (ONDANSETRON)